post-Emergency Use Authorization observational cohort study to evaluate the safety of the Pfizer-BioNTech bivalent COVID-19 vaccine
Clinical Trial Grant
Awarded By
Pfizer, Inc.
Start Date
April 18, 2023
End Date
November 30, 2025
Awarded By
Pfizer, Inc.
Start Date
April 18, 2023
End Date
November 30, 2025